Pycnogenol® Normalizes Cardio Risks During Perimenopause

Overview


Pycnogenol-R-Normalizes-Cardio-Risks-During-Perimenopause.png

A new study builds upon previous research showing the benefits of Pycnogenol® for alleviating perimenopause symptoms and is the first study to show effects on cardiovascular risk markers, homocysteine and CRP levels.

Daily Pycnogenol® supplementation reduced and normalized elevated cardiovascular risk factors often related to perimenopause: cholesterol, triglycerides, blood pressure and blood glucose. Participants also reported significant relief of hot flashes, reduction of night sweats and mood improvement.

This content is paid by Horphag Research, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Related Resources

Supplier Info Centre

Horphag-Research.jpg

For more product information visit Horphag Research.